- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Interferon-beta-1a (Avonex) plus methylprednisolone
Total 169 results
-
National Institute of Neurological Disorders and...CompletedTropical Spastic Paraparesis | Spinal Cord Disease | HTLV-I InfectionUnited States
-
Saint Francis CareBiogenCompleted
-
Johns Hopkins UniversityBiogenWithdrawn
-
Synairgen Research Ltd.CompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
BiogenCompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbHCompleted
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Germany, Russian Federation, India, New Zealand, Spain, Belgium, Colombia, Canada, Bulgaria, Serbia, Greece, Peru, Ukraine, Poland, United Kingdom, Croatia, France, Romania, Chile, Czech Republic, Mexico, Estonia, Georgia, Latv... and more
-
EMD SeronoPfizerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)United States
-
Synairgen Research Ltd.Completed
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing Remitting Multiple Sclerosis
-
EMD SeronoPfizerCompletedMultiple SclerosisUnited States
-
EMD SeronoTerminatedMultiple SclerosisUnited States
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedHealthy Subjects | Pharmacokinetics | PharmacodynamicsUnited States
-
BiogenRecruitingMultiple SclerosisUnited States, Germany
-
BiogenCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono Middle East FZ LLCCompletedRelapsing Multiple Sclerosis (RMS)Bulgaria, Poland, Argentina, Hungary, Korea, Republic of, Saudi Arabia, Egypt, Algeria, Bahrain, Iran, Islamic Republic of, Kuwait, Lebanon, Morocco
-
Beth Israel Deaconess Medical CenterBiogenCompletedMultiple Sclerosis | Optic Neuritis | Transverse Myelitis | Acute Brainstem/Cerebellar SyndromeUnited States, Canada
-
AstraZenecaCompletedAsthmaFrance, United Kingdom, Korea, Republic of, Argentina, Australia, Spain, Colombia
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisKorea, Republic of
-
CelgeneCompletedMultiple SclerosisUnited States, Spain, Czechia, Russian Federation, Portugal, Serbia, United Kingdom, New Zealand, Belarus, Bulgaria, Poland, Romania, Estonia, Germany, Sweden, Ukraine, Hungary, Croatia, Georgia, Bosnia and Herzegovina, Latvia, Li... and more
-
CelgeneCompletedRelapsing Multiple SclerosisSpain, United States, United Kingdom, Croatia, Serbia, Belarus, Hungary, Bulgaria, Poland, Italy, Ukraine, Greece, Belgium, Georgia, Bosnia and Herzegovina, Moldova, Republic of, Romania, Russian Federation, Slovakia, South Africa and more
-
University of California, San FranciscoOregon Health and Science University; National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Hoffmann-La RocheCompletedRelapsing Multiple SclerosisUnited States, Belgium, Czechia, Russian Federation, Serbia, Spain, Italy, Netherlands, Finland, Estonia, Brazil, France, Germany, Poland, Switzerland, Ukraine, Peru, Argentina, Lithuania, Slovakia, Portugal, Australia, Hungary, Tunisia, Bulgar... and more
-
Hoffmann-La RocheCompletedRelapsing Multiple SclerosisUnited States, Spain, Czechia, Belgium, Italy, Canada, United Kingdom, Germany, Ireland, Turkey, Poland, Russian Federation, Ukraine, Croatia, Argentina, France, Belarus, Brazil, Mexico, Bosnia and Herzegovina, Bulgaria, Slovakia, S... and more
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden and other collaboratorsCompletedMultiple Sclerosis, Relapsing RemittingGreece
-
Faron Pharmaceuticals LtdTerminatedPreventive Medicine | Multi Organ FailureLithuania, Estonia, Finland
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
EMD SeronoTerminatedCrohn's DiseaseGermany, Italy, Sweden, Switzerland, United Kingdom
-
BiogenCompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-Remitting
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, FranceCompletedMultiple Sclerosis, Relapsing, Remitting
-
National Institute of Neurological Disorders and...Completed
-
BiogenCompleted
-
BiogenCompletedHealthy VolunteersUnited States
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
German University in CairoRecruiting
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
BiocadCompletedHealthyRussian Federation
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.P.A., ItalyCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
BiogenCompletedMultiple SclerosisSweden, France, United Kingdom, Germany, Denmark, Netherlands, Slovakia, Switzerland, Norway, Portugal
-
Qassim UniversityUnknown
-
Aaron BosterPfizer; EMD SeronoCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.P.A., ItalyCompleted
-
Shahid Beheshti University of Medical SciencesUnknown